Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02667587 : An Investigational Immuno-therapy Study of Temozolomide Plus Radiation Therapy With Nivolumab or Placebo, for Newly Diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)
PhasePhase 3
AgesMin: 18 Years Max: N/A
Eligibility
For more information regarding Bristol-Myers Squibb Clinical Trial participation, please
visit www.BMSStudyConnect.com

Inclusion Criteria:

- Males and Females, age ? 18 years old

- Newly diagnosed brain cancer or tumor called glioblastoma or GBM

- Karnofsky performance status of ? 70 (able to take care of self)

- Substantial recovery from surgery resection

- Tumor test result shows MGMT methylated or indeterminate tumor subtype

Exclusion Criteria:

- Biopsy-only of GBM with less than 20% of tumor removed

- Prior treatment for GBM (other than surgical resection)

- Any known tumor outside of the brain

- Recurrent or secondary GBM

- Active known or suspected autoimmune disease

Other protocol defined inclusion/exclusion criteria could apply
LinksPermanent Link to THIS page: http://virtualtrials.com/nct/display1trial.cfm?nct=NCT02667587      |      Link to official Clinicaltrials.gov listing
Locations
Liverpool, New South Wales
Australia

Facility: Local Institution
Investigator:
Contact: Site 0049
Email not avaialable

St. Leonards, New South Wales
Australia

Facility: Royal North Shore Hospital
Investigator:
Contact: Mustafa Khasraw, Site 0052 Phone: +61294631373
Email not avaialable

Heidelberg, Victoria
Australia

Facility: Local Institution
Investigator:
Contact: Site 0050
Email not avaialable

Prahran, Victoria
Australia

Facility: Local Institution
Investigator:
Contact: Site 0051
Email not avaialable

Nedlands, Western Australia
Australia

Facility: Sir Charles Gairdner Hospital
Investigator:
Contact: Anna Nowak, Site 0122 Phone: +61408818656
Email not avaialable

Linz,
Austria

Facility: Kepler Universitaetsklinikum
Investigator:
Contact: Josef Pichler, Site 0062
Email not avaialable

Vienna,
Austria

Facility: Medical University Of Vienna
Investigator:
Contact: Matthias Preusser, Site 0061
Email not avaialable

Brussels,
Belgium

Facility: Universitair Ziekenhuis Brussel
Investigator:
Contact: Bart Neyns, Site 0070 Phone: +3224775457
Email not avaialable

Bruxelles,
Belgium

Facility: Cliniques Universitaires Saint-Luc
Investigator:
Contact: Nicolas Whenham, Site 0069 Phone: +3210437147
Email not avaialable

Leuven,
Belgium

Facility: Uz Leuven
Investigator:
Contact: Paul Clement, Site 0071 Phone: +3216346903
Email not avaialable

Vancouver, British Columbia
Canada

Facility: British Columbia Cancer Agency-Vancouver Ctr
Investigator:
Contact: Brian Thiessen, Site 0046 Phone: 6048776000
Email not avaialable

Toronto, Ontario
Canada

Facility: Princess Margaret Cancer Centre
Investigator:
Contact: Warren Mason, Site 0048 Phone: 4165817823
Email not avaialable

Montreal, Quebec
Canada

Facility: Montreal Neurological Institute and Hospital
Investigator:
Contact: Kevin Petrecca, Site 0047 Phone: 5143982801
Email not avaialable

Copenhagen,
Denmark

Facility: Local Institution
Investigator:
Contact: Site 0084
Email not avaialable

Odense C,
Denmark

Facility: Local Institution
Investigator:
Contact: Site 0085
Email not avaialable

Lille Cedex,
France

Facility: Local Institution
Investigator:
Contact: Site 0043
Email not avaialable

Lyon Cedex 03,
France

Facility: Local Institution
Investigator:
Contact: Site 0041
Email not avaialable

Marseille,
France

Facility: Local Institution
Investigator:
Contact: Site 0040
Email not avaialable

Nancy,
France

Facility: Local Institution
Investigator:
Contact: Site 0042
Email not avaialable

Paris,
France

Facility: Local Institution
Investigator:
Contact: Site 0038
Email not avaialable

Paris cedex 13,
France

Facility: Local Institution
Investigator:
Contact: Site 0039
Email not avaialable

Rennes Cedex,
France

Facility: Local Institution
Investigator:
Contact: Site 0044
Email not avaialable

Toulouse,
France

Facility: Local Institution
Investigator:
Contact: Site 0045
Email not avaialable

Bonn,
Germany

Facility: Universitaetsklinikum Bonn
Investigator:
Contact: Ulrich Herrlinger, Site 0055 Phone: +4922828719887
Email not avaialable

Erlangen,
Germany

Facility: Uniklinik Erlangen
Investigator:
Contact: Martin Uhl, Site 0123 Phone: +4991318534640
Email not avaialable

Frankfurt Am Main,
Germany

Facility: Klinikum Der J. W. Goethe-Universitaet Frankfurt/Main
Investigator:
Contact: Oliver Baehr, Site 0053 Phone: +4969630187711
Email not avaialable

Freiburg,
Germany

Facility: Medizinische Universitaetsklinik Freiburg
Investigator:
Contact: Oliver Schnell, Site 0124
Email not avaialable

Hamburg,
Germany

Facility: Universitaetsklinikum Hamburg
Investigator:
Contact: Manfred Westphal, Site 0057 Phone: +4940741035316
Email not avaialable

Heidelberg,
Germany

Facility: Universitaetsklinik Heidelberg
Investigator:
Contact: Antje Wick, Site 0056 Phone: +4962215638265
Email not avaialable

Koeln,
Germany

Facility: Universitaetsklinik Koeln
Investigator:
Contact: Norbert Galldiks, Site 0131
Email not avaialable

Muenster,
Germany

Facility: Universitaetsklinikum Muenster
Investigator:
Contact: Oliver Grauer, Site 0054 Phone: +492518346814
Email not avaialable

Munich,
Germany

Facility: Klinikum rechts der Isar der Technischen Universitat Munchen
Investigator:
Contact: Stephanie Combs, Site 0130
Email not avaialable

Regensburg,
Germany

Facility: Local Institution
Investigator:
Contact: Site 0058
Email not avaialable

Tuebingen,
Germany

Facility: Universitasklinikum Tubingen
Investigator:
Contact: Ghazaleh Tabatabai, Site 0059 Phone: +491729031130
Email not avaialable

Petach Tikva,
Israel

Facility: Local Institution
Investigator:
Contact: Site 0094
Email not avaialable

Tel Aviv,
Israel

Facility: Local Institution
Investigator:
Contact: Site 0093
Email not avaialable

Bologna,
Italy

Facility: Local Institution
Investigator:
Contact: Site 0088
Email not avaialable

Milano,
Italy

Facility: Local Institution
Investigator:
Contact: Site 0089
Email not avaialable

Padova,
Italy

Facility: Local Institution
Investigator:
Contact: Site 0092
Email not avaialable

Rozzano (milano),
Italy

Facility: Local Institution
Investigator:
Contact: Site 0127
Email not avaialable

Siena,
Italy

Facility: Local Institution
Investigator:
Contact: Site 0090
Email not avaialable

Torino,
Italy

Facility: Local Institution
Investigator:
Contact: Site 0091
Email not avaialable

Kyoto,
Japan

Facility: Local Institution
Investigator:
Contact: Site 0109
Email not avaialable

Nagoya-shi, Aichi
Japan

Facility: Local Institution
Investigator:
Contact: Site 0110
Email not avaialable

Chiba-shi, Chiba
Japan

Facility: Local Institution
Investigator:
Contact: Site 0099
Email not avaialable

Hiroshima-Shi, Hiroshima
Japan

Facility: Local Institution
Investigator:
Contact: Site 0100
Email not avaialable

Sapporo-shi, Hokkaido
Japan

Facility: Local Institution
Investigator:
Contact: Site 0101
Email not avaialable

Kobe-shi, Hyogo
Japan

Facility: Local Institution
Investigator:
Contact: Site 0105
Email not avaialable

Tsukuba-shi, Ibaraki
Japan

Facility: Local Institution
Investigator:
Contact: Site 0116
Email not avaialable

Kanazawa-shi, Ishikawa
Japan

Facility: Local Institution
Investigator:
Contact: Site 0103
Email not avaialable

Kagoshima-shi, Kagoshima
Japan

Facility: Local Institution
Investigator:
Contact: Site 0102
Email not avaialable

Sagamihara-shi, Kanagawa
Japan

Facility: Local Institution
Investigator:
Contact: Site 0118
Email not avaialable

Kumamoto-shi, Kumamoto
Japan

Facility: Local Institution
Investigator:
Contact: Site 0106
Email not avaialable

Kyoto-shi, Kyoto
Japan

Facility: Local Institution
Investigator:
Contact: Site 0108
Email not avaialable

Okayama-shi, Okayama
Japan

Facility: Local Institution
Investigator:
Contact: Site 0120
Email not avaialable

Hirakata-shi, Osaka
Japan

Facility: Local Institution
Investigator:
Contact: Site 0104
Email not avaialable

Suita-shi, Osaka
Japan

Facility: Local Institution
Investigator:
Contact: Site 0112
Email not avaialable

Hidaka-shi, Saitama
Japan

Facility: Local Institution
Investigator:
Contact: Site 0121
Email not avaialable

Bunkyo-ku, Tokyo
Japan

Facility: Local Institution
Investigator:
Contact: Site 0114
Email not avaialable

Chuo-ku, Tokyo
Japan

Facility: Local Institution
Investigator:
Contact: Site 0111
Email not avaialable

Mitaka-shi, Tokyo
Japan

Facility: Local Institution
Investigator:
Contact: Site 0107
Email not avaialable

Shinjuku-ku, Tokyo
Japan

Facility: Local Institution
Investigator:
Contact: Site 0115
Email not avaialable

Yamagata-shi, Yamagata
Japan

Facility: Local Institution
Investigator:
Contact: Site 0117
Email not avaialable

Amsterdam,
Netherlands

Facility: NKI AVL
Investigator:
Contact: Dieta Brandsma, Site 0075 Phone: +31205122570
Email not avaialable

Groningen,
Netherlands

Facility: Universitair Medisch Centrum Groningen
Investigator:
Contact: Annemiek Walenkamp, Site 0074 Phone: +31503616161
Email not avaialable

Rotterdam,
Netherlands

Facility: Erasmus Mc
Investigator:
Contact: Martin Van Den Bent, Site 0073 Phone: +31107041415
Email not avaialable

Utrecht,
Netherlands

Facility: Universitair Medisch Centrum Utrecht
Investigator:
Contact: Filip De Vos, Site 0072 Phone: +31887556263
Email not avaialable

Oslo,
Norway

Facility: Local Institution
Investigator:
Contact: Site 0083
Email not avaialable

Gdansk,
Poland

Facility: Uniwersyteckie Centrum Kliniczne Klinika Onkologii I Radiote
Investigator:
Contact: Renata Zaucha, Site 0086 Phone: +48583492257
Email not avaialable

Moscow,
Russian Federation

Facility: Local Institution
Investigator:
Contact: Site 0095
Email not avaialable

Badalona-barcelona,
Spain

Facility: Local Institution
Investigator:
Contact: Site 0126
Email not avaialable

Barcelona,
Spain

Facility: Local Institution
Investigator:
Contact: Site 0078
Email not avaialable

Barcelona,
Spain

Facility: Local Institution
Investigator:
Contact: Site 0125
Email not avaialable

Madrid,
Spain

Facility: Local Institution
Investigator:
Contact: Site 0077
Email not avaialable

Madrid,
Spain

Facility: Local Institution
Investigator:
Contact: Site 0076
Email not avaialable

Santiago Compostela,
Spain

Facility: Local Institution
Investigator:
Contact: Site 0080
Email not avaialable

Valencia,
Spain

Facility: Local Institution
Investigator:
Contact: Site 0079
Email not avaialable

Lund,
Sweden

Facility: Local Institution
Investigator:
Contact: Site 0081
Email not avaialable

Stockholm,
Sweden

Facility: Local Institution
Investigator:
Contact: Site 0082
Email not avaialable

Geneve,
Switzerland

Facility: University Hospital Geneva
Investigator:
Contact: Pierre-Yves Dietrich, Site 0065 Phone: +41223729861
Email not avaialable

Lausanne,
Switzerland

Facility: Centre hospitalier universitaire Vaudois (CHUV)
Investigator:
Contact: Andreas Hottinger, Site 0064
Email not avaialable

Zuerich,
Switzerland

Facility: UniversitaetsSpital Zurich
Investigator:
Contact: Patrick Roth, Site 0063
Email not avaialable

Glasgow,
United Kingdom

Facility: Beaston West of Scotland Cancer Centre
Investigator:
Contact: Stefan Nowicki, Site 0068 Phone: +441413017000
Email not avaialable

London, Greater London
United Kingdom

Facility: University College Hospital
Investigator:
Contact: Paul Mulholland, Site 0067 Phone: +444473809358
Email not avaialable

Manchester, Greater Manchester
United Kingdom

Facility: Christie Hospital Nhs Found. Trust
Investigator:
Contact: Catherine Mcbain, Site 0066 Phone: +441614463000
Email not avaialable

Sutton, Surrey
United Kingdom

Facility: Royal Marsden Hospital
Investigator:
Contact: Frank Saran, Site 0119
Email not avaialable

Birmingham, Alabama
Facility: University of Alabama at Birmingham
Investigator:
Contact: Louis Nabors, Site 0023 Phone: 205-934-1842
Email not avaialable

Phoenix, Arizona
Facility: St. Joseph Hospital And Medical Center
Investigator:
Contact: Surasak Phuphanich, Site 0003
Email not avaialable

Los Angeles, California
Facility: Cedars Sinai Medical Center
Investigator:
Contact: Jeremy Rudnick, Site 0026 Phone: 310-423-4513
Email not avaialable

Los Angeles, California
Facility: UCLA Neuro-Oncology Program
Investigator:
Contact: Timothy Cloughesy, Site 0010 Phone: 310-794-3521
Email not avaialable

Sacramento, California
Facility: Sutter Institute For Medical Research
Investigator:
Contact: Stacy Dandre, Site 0128 Phone: 916-453-5800
Email not avaialable

San Diego, California
Facility: Sharp Memorial Hospital
Investigator:
Contact: Charles Redfern, Site 0029 Phone: 619-502-3241
Email not avaialable

San Francisco, California
Facility: The Regents of the University of California, San Francisco
Investigator:
Contact: Jennie Taylor, Site 0006
Email not avaialable

New Haven, Connecticut
Facility: Yale University School Of Medicine
Investigator:
Contact: Joachim Baehring, Site 0004 Phone: 203-785-7486
Email not avaialable

Washington, D.C., District of Columbia
Facility: Georgetown University
Investigator:
Contact: Deepa Subramaniam, Site 0031 Phone: 202-687-8962
Email not avaialable

Miami, Florida
Facility: University Of Miami Sylvester Comprehensive Cancer Center
Investigator:
Contact: Macarena De La Fuente, Site 0087 Phone: 305-243-3111
Email not avaialable

Tampa, Florida
Facility: Moffitt Cancer Center
Investigator:
Contact: Solmaz Sahebjam, Site 0030 Phone: 813-745-7991
Email not avaialable

Westwood, Kansas
Facility: University Of Kansas Medical Center
Investigator:
Contact: Michael Salacz, Site 0060 Phone: 913-588-1886
Email not avaialable

Louisville, Kentucky
Facility: Norton Cancer Institute
Investigator:
Contact: Renato La Rocca, Site 0018
Email not avaialable

Baltimore, Maryland
Facility: Johns Hopkins University School Of Medicine
Investigator:
Contact: Michael Lim, Site 0020
Email not avaialable

Boston, Massachusetts
Facility: Dana-Farber Cancer Institute
Investigator:
Contact: David Reardon, Site 0028 Phone: 617-632-4876
Email not avaialable

Boston, Massachusetts
Facility: Massachusetts General Hospital
Investigator:
Contact: David Reardon, Site 0011 Phone: 617-643-1933
Email not avaialable

Detroit, Michigan
Facility: Henry Ford Health System
Investigator:
Contact: Tobias Walbert, Site 0035
Email not avaialable

Saint Louis, Missouri
Facility: Washington University School Of Medicine
Investigator:
Contact: George Ansstas, Site 0002 Phone: 314-286-0896
Email not avaialable

Edison, New Jersey
Facility: JFK Medical Center
Investigator:
Contact: Joseph Landolfi, Site 0017 Phone: 732-321-7000
Email not avaialable

Hackensack, New Jersey
Facility: Hackensack University Medical Center
Investigator:
Contact: Samuel Goldlust, Site 0012 Phone: 551-996-5098
Email not avaialable

New York, New York
Facility: Columbia University
Investigator:
Contact: Fabio Iwamoto, Site 0015 Phone: 212-304-5530
Email not avaialable

New York, New York
Facility: Memorial Sloan Kettering Cancer Center
Investigator:
Contact: Mariza Daras, Site 0024
Email not avaialable

Charlotte, North Carolina
Facility: Levine Cancer Institute
Investigator:
Contact: Ashley Sumrall, Site 0032 Phone: 980-442-5300
Email not avaialable

Durham, North Carolina
Facility: Preston Robert Tisch Brain Tumor Center at Duke University
Investigator:
Contact: Katherine Peters, Site 0033 Phone: 919-681-9932
Email not avaialable

Cleveland, Ohio
Facility: Cleveland Clinic
Investigator:
Contact: Manmeet Ahluwalia, Site 0001 Phone: 216-445-3407
Email not avaialable

Columbus, Ohio
Facility: The Ohio State University Wexner Medical Center
Investigator:
Contact: Raju Raval, Site 0027 Phone: 614-685-2435
Email not avaialable

Allentown, Pennsylvania
Facility: Lehigh Valley Health Network
Investigator:
Contact: Suresh Nair, Site 0098 Phone: 610-402-0636
Email not avaialable

Philadelphia, Pennsylvania
Facility: Thomas Jefferson University
Investigator:
Contact: Lyndon Kim, Site 0016 Phone: 215-503-9110
Email not avaialable

Charleston, South Carolina
Facility: Medical University Of South Carolina
Investigator:
Contact: Scott Lindhorst, Site 0021 Phone: 843-792-9016
Email not avaialable

Chattanooga, Tennessee
Facility: Erlanger Oncology & Hematology - Univ. of TN
Investigator:
Contact: Robert Graham, Site 0013 Phone: 423-778-2982
Email not avaialable

Nashville, Tennessee
Facility: Vanderbilt University Medical Center
Investigator:
Contact: Stephen Clark, Site 0008 Phone: 615-936-8606
Email not avaialable

Dallas, Texas
Facility: University Of Texas Southwestern Medical Center
Investigator:
Contact: Edward Pan, Site 0025 Phone: 214-648-1929
Email not avaialable

Salt Lake City, Utah
Facility: Huntsman Cancer Institute
Investigator:
Contact: Adam Cohen, Site 0009 Phone: 801-587-4433
Email not avaialable

Seattle, Washington
Facility: Swedish Neuroscience Institute
Investigator:
Contact: Tara Benkers, Site 0005 Phone: 206-386-3878
Email not avaialable




Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites